Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer

@inproceedings{Holz2017RiskFA,
  title={Risk factor assessment in high-risk, bacillus Calmette–Gu{\'e}rin-treated, non-muscle-invasive bladder cancer},
  author={Serge Holz and Simone Albisinni and Jacques Gilsoul and Michel Pirson and V{\'e}ronique Duthie and Thierry Quackels and Marc Vanden Bossche and Thierry Roumegu{\`e}re},
  booktitle={Research and reports in urology},
  year={2017}
}
OBJECTIVE To assess the risk factors associated with recurrence, progression and survival in high-risk non-muscle-invasive bladder cancer (NMIBC) patients treated with bacillus Calmette-Guérin (BCG) and validate the European Organization for Research and Treatment of Cancer (EORTC) and Spanish Urological Club for Oncological Treatment (CUETO) scores. PATIENTS AND METHODS We retrospectively analyzed all BCG-treated NMIBC patients from 1998 to 2012. Multiple variables were tested as risk… CONTINUE READING